In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

ESSA Pharma Inc.. Trade Record

NASDAQ:EPIX ESSA Pharma Inc. stock gains 5.00% Exit Sep 6, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart EPIX Aug 31, 2018, priceSeries
About ESSA Pharma Inc.

ESSA Pharma Inc., a clinical-stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Trade Information
Trade Type
LONG
ReliabilityScore™
81.82
Entry Date
Aug 31, 2018
Entry Price
3.25
Sell Date
Sep 6, 2018
Sell Price
3.41
Net Gain
5.00%
Hold Time
3 Trading Days